1.
Peter Dreger, Michael Rieger, Bärbel Seyfarth, Manfred Hensel, Michael Kneba, Anthony D. Ho, Norbert Schmitz, Christiane Pott. Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome. haematol [Internet]. 2007Jan.1 [cited 2020Oct.26];92(1):42-9. Available from: https://haematologica.org/article/view/4303